AFFIVANT
Affivant is committed to the development of novel immuno-oncology techniques that will stimulate and enable the innate immune system to fight cancer.
AFFIVANT
Social Links:
Industry:
Biotechnology Market Research Oncology
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.affivant.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
U.S. Server Location
Similar Organizations
Abingworth
Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs.
Actym Therapeutics, Inc.
Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.
Apeximmune Therapeutics
Apeximmune Therapeutics engages in the discovery and development of novel biologics that modulate the immune system.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
CDR-Life AG
CDR-Life AG is a biotech company that develops innovative therapeutic antibody fragments with a focus on immuno-oncology.
Exacis Biotherapeutics
Exacis is a development-stage immuno-oncology company focused on harnessing the human immune system to cure cancer.
Haemalogix
Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.
NBE-Therapeutics
NBE-Therapeutics is a biotech company that develops oncology treatments for cancer patients.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
